関連する実験動画
Updated: Jun 1, 2026

07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
ワクチンの生産,配布,アクセス,利用について
Jon Smith1, Marc Lipsitch, Jeffrey W Almond
1Sanofi Pasteur, Marcy L'Etoile, France.
Lancet (London, England)
|June 14, 2011
まとめ
世界的なワクチンの利用可能性は,効率的な生産,品質管理,配布に依存しています. ワクチンの普及率を最適化するには,強力なパートナーシップと戦略的優先順位付けが必要です.
科学分野:
- ワクチン学 ワクチン学
- 公衆衛生は公衆衛生である.
- 製薬製造業 製薬製造業
背景:
- 世界的なワクチンのアクセシビリティは,複雑な製造,厳格な品質管理,配布の課題によって制限されています.
- ワクチンの技術は,コスト,スケーラビリティ,安定性,世界的な利用可能性に大きく影響を与えます.
- 異なる国や年齢の人口統計に合わせて,異なる配方が必要であり,複雑さを増している.
研究 の 目的:
- 世界規模でワクチン生産,配布,アクセス,利用に影響を与える要因を分析する.
- ワクチンの利用可能性とコストを決定する際の製造技術の重要性を強調する.
- インフルエンザワクチンをモデルとして用いて,ワクチンの有効性と人口レベルの影響を高めるための戦略を検証する.
主な方法:
- インフルエンザワクチンを中心にワクチンの開発経験のレビュー.
- 生産技術の分析と,そのスケーラビリティと安定性への影響.
- 流通チャネル,規制枠組み,公私パートナーシップの検討.
主要な成果:
- 製造の複雑性と配方多様性は,世界的なワクチン供給に重大な障害をもたらします.
- 低価格で信頼性の高いワクチンの生産は,効果的な世界的なワクチン接種政策に不可欠です.
- 戦略的優先順位設定と強力なコラボレーションは,ワクチンのアクセスと普及を最適化するために不可欠です.
結論:
- 製造,流通,アクセスの課題に対処することは,世界的なワクチンの公平性にとって極めて重要です.
- ワクチンの製造における技術的選択は,世界的な健康結果に直接影響します.
- 製造業者,規制当局,公衆衛生機関間の協力的な取り組みは,ワクチン効果を最大化するための鍵です.
関連する概念動画
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccinations
Overview
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Primary Healthcare Services
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
